Although some subgroup analysis results indicated a favorable trend in the L. reuteri supplementation group, there was no statistical difference due to the limited number of articles included.
← all excerpts
<i>Lactobacillus reuteri</i> compared with placebo as an adjuvant in <i>Helicobacter pylori</i> eradication therapy: a meta-analysis of randomized controlled trials.
1
—
—